Ординатура / Офтальмология / Английские материалы / Retinal Degenerations biology, diagnostics, and therapeutics_Tombran-Tink, Barnstable_2007

46.Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol Chem 1999;274:8269–8281.

47.Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell 1999;98:13–23.

48.Molday RS, Molday LL. Identification and characterization of multiple forms of rhodopsin and minor proteins in frog and bovine outer segment disc membranes. Electrophoresis, lectin labeling and proteolysis studies. J Biol Chem 1979;254:4653–4660.

49.Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000;25:257–258.

50.Papermaster DS, Schneider BG, Zorn MA, Kraehenbuhl JP. Immunocytochemical localization of a large intrinsic membrane protein to the incisures and margins of frog rod outer segment disks. J Cell Biol 1978;78:415–425.

51.Sun H, Nathans J. Stargardt’s ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet 1997;17:15–16.

52.Sun H, Nathans J. Mechanistic studies of ABCR, the ABC transporter in photoreceptor outer segments responsible for autosomal recessive Stargardt disease. J Bioenerg Biomembrane 2001;33:523–530.

53.Sun H, Nathans J. ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-trans retinal-mediated photo-oxidative damage in vitro: implications for retinal disease. J Biol Chem 2001;276:11,766–11,774.

54.Beharry S, Zhong M, Molday RS. N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J Biol Chem 2004;279(52):53,972–53,979.

55.Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997; 15:236–246.

56.Sparrow JR. Therapy for macular degeneration: insignts from acne. Proc Natl Acad Sci USA 2003;100:4353–4354.

57.Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA 2000;97:7154–7159.

58.Young RW. The renewal of rod and cone outer segments in the rhesus monkey. J Cell Biol 1971;49:303–318.

59.Katz ML, Drea CM, Eldred GE, Hess HH, Robison WG Jr. Influence of early photoreceptor degeneration on lipofuscin in the retinal pigment epithelium. Exp Eye Res 1986;43:561–573.

60.Eldred GE. The fluorophores of the RCS rat retina and implications for retinal degeneration. In: Hollyfield JG, Anderson RE, La Vail MM, eds. Retinal Degenerations. Boca Raton, Florida: CRC Press, 1991.

61.Birnbach CD, Jarvelainen M, Possin DE, Milam AH. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 1994; 101:1211–1219.

62.Bunt-Milam AH, Kalina RE, Pagon RA. Clinical-ultrastructural study of a retinal dystrophy. Invest Ophthalmol Vis Sci 1983;24:458–469.

63.Szamier RB, Berson EL. Retinal ultrastructure in advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci 1977;16:947–962.

64.Ahn J, Wong JT, Molday RS. The effect of lipid environment and retinoids on the ATPase activity of ABCR, the photoreceptor ABC transporter responsible for Stargardt macular dystrophy. J Biol Chem 2000;275:20,399–20,405.

65.Illing M, Molday LL, Molday RS. The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J Biol Chem 1997;272:10,303–10,310.

66.Saari JC, Garwin GG, Van Hooser JP, Palczewski K. Reduction of all-trans-retinal limits regeneration of visual pigment in mice. Vision Res 1998;38:1325–1333.

67.Kim SR, Fishkin N, Kong J, Nakanishi K, Allikmets R, Sparrow JR. The Rpe65 Leu450Met variant is associated with reduced levels of the RPE lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci USA 2004;101:11,668–11,672.

68.Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH. Delayed dark adaptation and lipofuscin accumulation in abcr+/− mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1685–1690.

69.Xue L, Gollapalli DR, Maiti P, Jahng WJ, Rando RR. A palmitoylation switch mechanism in the regulation of the visual cycle. Cell 2004;117:761–771.

70.Wenzel A, Reme CE, Williams TP, Hafezi F, Grimm C. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J Neurosci 2001;21:53–58.

71.Danciger M, Matthes MT, Yasamura D, et al. A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mam Genome 2000;11:422–427.

72.Nusinowitz S, Nguyen L, Radu RA, Kashani Z, Farber DB, Danciger M. Electroretinographic evidence for altered phototransduction gain and slowed recovery from photobleaches in albino mice with a MET450 variant in RPE6. Exp Eye Res 2003;77:627–638.

73.Wenzel A, Grimm C, Samardzija M, Reme CE. The genetic modified Rpe65Leu450: effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci 2003;44:2798–2802.

74.Sieving PA, Chaudhry P, Kondo M, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA 2001;98:1835–1840.

75.Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin and A2E accumulation in a mouse model of recessive Stargardt’s macular degeneration. Proc Natl Acad Sci USA 2003;100:4742–4747.

76.Eldred GE, Miller GV, Stark WS, Feeney-Burns L. Lipofuscin: resolution of discrepant fluorescence data. Science 1982;216:757–758.

77.Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718–729.

78.Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000;41:1981–1989.

79.Lamb LE, Ye T, Haralampus-Grynaviski NM, et al. Primary photophysical properties of A2E in solution. J Phys Chem B 2001;105:11,507–11,512.

80.Sparrow JR, Parish CA, Hashimoto M, Nakanishi K. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999;40:2988–2995.

81.De S, Sakmar TP. Interaction of A2E with model membranes. Implications to the pathogenesis of age-related macular degeneration. J Gen Physiol 2002;120:147–157.

82.Ragauskaite L, Heckathorn RC, Gaillard ER. Environmental effects on the photochemistry of A2E, a component of human retinal lipofuscin. Photochem Photobiol 2001; 74:483–488.

83.Delori FC. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Appl Optics 1994;33:7439–7452.

84.von Rückmann A, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 1997;38:478–486.

85.Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 2004;430:156–162.

86.Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 1989;30:1691–1699.

87.Docchio F, Boulton M, Cubeddu R, Ramponi R, Barker PD. Age-related changes in the fluorescence of melanin and lipofuscin granules of the retinal pigment epithelium: a time-resolved fluorescence spectroscopy study. Photochem Photobiol 1991; 54:247–253.

88.Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 1986;27:145–151.

89.Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 1993;34:3278–3296.

90.Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 2002;43:3312–3318.

91.Weiter JJ, Delori FC, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol 1988;106:286–290.

92.Marmorstein AD, Marmorstein LY, Sakaguchi H, Hollyfield JG. Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s Membrane, and sub-RPE deposits in normal and AMD eyes. Invest Ophthalmol Vis Sci 2002;43:2435–2441.

93.Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1051–1056.

94.Lois N, Owens SL, Coco R, Hopkins J, Fitzke FW, Bird AC. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol 2002;133:341–349.

95.Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:496–504.

96.Solbach U, Keilhauer C, Knabben H, Wolf S. Imaging of retinal autofluorescence in patients with age-related macular degeneration. Retina 1997;17:385–389.

97.Holz FG, Bellmann C, Margaritidis M, Schutt F, Otto TP, Volcker HE. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol 1999;237:145–152.

98.Rozanowska M, Korytowski W, Rozanowska B, et al. Photoreactivitiy of aged human RPE melanosomes: a comparison with lipofuscin. Invest Ophthalmol Vis Sci 2002;43:2088–2096.

99.Pawlak A, Rozanowska M, Zareba M, Lamb LE, Simon JD, Sarna T. Action spectra for the photoconsumptioin of oxygen by human ocular lipofuscin and lipofuscin extracts. Arch Biochem Biophys 2002;403:59–62.

100.Rozanowska M, Pawlak A, Rozanowska B, et al. Age-related changes in the photoreactivity of retinal lipofuscin granules: role of chloroform-insoluble components. Invest Ophthalmol Vis Sci 2004;45:1052–1060.

101.Reszka K, Eldred GE, Wang RH, Chignell C, Dillon J. The photochemistry of human retinal lipofuscin as studied by EPR. Photochem Photobiol 1995;62:1005–1008.

102.Gaillard ER, Atherton SJ, Eldred G, Dillon J. Photophysical studies on human retinal lipofuscin. Photochem Photobiol 1995;61:448–453.

103.Pawlak A, Wrona M, Rozanowska M, et al. Comparison of the aerobic photoreactivity of A2E with its precursor retinal. Photochem Photobiol 2003;77:253–258.

104.Kanofsky JR, Sima PD, Richter C. Singlet-oxygen generation from A2E. Photochem Photobiol 2003;77:235–242.

105.Cantrell A, McGarvey DJ, Roberts J, Sarna T, Truscott TG. Photochemical studies of A2E. J Photochem Photobiol B: Biology 2001;64:162–165.

106.Bunting JR. A test of the singlet oxygen mechanism of cationic dye photosensitization of mitochondrial damage. Photochem Photobiol 1992;55:81–87.

107.Delaey E, van Laar F, De Vos D, Kamuhabwa A, Jacobs P, de Witte P. A comparative study of the photosensitizing characteristics of some cyanine dyes. J Photochem Photobiol B 2000;55:27–36.

108.Krieg M, Srichai MB, Redmond RW. Photophysical properties of 3,3’-dialkylthiacarbo- cyanine dyes in organized media: unilamellar liposomes and thin polymer films. Biochim Biophys Acta 1993;1151:168–174.

109.Gaillard ER, Avalle LB, Keller LMM, Wang Z, Reszka KJ, Dillon JP. A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp Eye Res 2004;79:313–319.

110.Roberts JE, Kukielczak BM, Hu DN, et al. The role of A2E in prevention or enhancement of light damage in human retinal pigment epithelial cells. Photochem Photobiol 2002;75:184–190.

111.Schmucker DL, Sachs H. Quantifying dense bodies and lipofuscin during aging: a morphologist’s perspective. Arch Gerontol Geriatr 2002;34:249–261.

112.De S, Sakmar TP. Interaction of A2E with model membranes. Implications to the pathogenesis of age-related macular degeneration. J Gen Physiol 2002;120:147–157.

113.Bergmann M, Schutt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2E may contribute to the pathogenesis of age-related macular degeneration. FASEB J 2004;18:562–564.

114.Holz FG, Schutt F, Kopitz J, et al. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 1999;40: 737–743.

115.Berman M, Schutt F, Holz FG, Kopitz J. Does A2E, a retinoid component of lipofuscin and inhibitor of lysosomal degradative functions, directly affect the activity of lysosomal hydrolases. Exp Eye Res 2001;72:191–195.

116.Finneman SC, Leung LW, Rodriguez-Boulan E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci USA 2002;99:3842–3847.

117.Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000;41: 2303–2308.

118.Sparrow JR, Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 2001;42: 1356–1362.

119.Ham WTJ, Allen RG, Feeney-Burns L, et al. The involvement of the retinal pigment epithelium. In: Waxler M, Hitchins VM, eds. CRC Optical Radiation and Visual Health. Boca Raton, Florida: CRC Press, Inc., 1986:43–67.

120.Ham WT, Mueller HA, Ruffolo JJ, et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984;3:165–174.

120a. Busch EM, Gorgels TGMF, Roberts JE, van Norren D. The effects of two stereoisomers of N-acetylcysteine on photochemical damage by UVA and blue light in rat retina. Photochem Photobiol 1999;70:353–358.

121.Borges J, Li Z-Y, Tso MO. Effects of repeated photic exposures on the monkey macula. Arch Ophthalmol 1990;108:727–733.

122.Putting BJ, Van Best JA, Vrensen GFJM, Oosterhuis JA. Blue-light-induced dysfunction of the blood-retinal barrier at the pigment epithelium in albino versus pigmented rabbits. Exp Eye Res 1994;58:31–40.

123.Paultler EL, Morita M, Beezley D. Reversible and irreversible blue light damage to the isolated mammalian pigment epithelium. In: La Vail MM, Anderson RE, Hollyfield JG, eds. Inherited and Environmental Induced Retinal Degeneration. New York: Alan R. Liss, 1989;555–567.

124.Sparrow JR, Zhou J, Cai B. DNA is a target of the photodynamic effects elicited in A2Eladen RPE by blue light illumination. Invest Ophthalmol Vis Sci 2003;44:2245–2251.

125.Sparrow JR, Vollmer-Snarr HR, Zhou J, et al. A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem 2003;278:18,207–18,213.

126.Eagle RC, Lucier AC, Bernardino VB, Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmol 1980;87:1189–1200.

127.Lois N, Holder GE, Fitzke FW, Plant C, Bird AC. Intrafamilial variation of phenotype in Stargardt macular dystrophy-fundus flavimaculatus. Invest Ophthalmol Vis Sci 1999;40:2668–2675.

128.Lopez PF, Maumenee IH, de la Cruz Z, Green WR. Autosomal-dominant fundus favimaculatus. Clinicopathologic correlation. Ophthalmol 1990;97:798–809.

129.Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805–1807.

130.Shroyer NF, Lewis RA, Yatsenko AN, Lupski JR. Null missense ABCR (ABCA4) mutations in a family with Stargardt disease and retinitis pigmentosa. Invest Ophthalmol Vis Sci 2001;42:2757–2761.

131.Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 2001;10: 2671–2678.

132.Yatsenko AN, Shroyer NF, Lewis RA, Lupski JR. Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4). Hum Genet 2001;108:346–355.

133.Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt’s disease—Fundus flavimaculatus. Invest Ophthalmol Vis Sci 1995;36:2327–2331.

134.von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 1997;115:609–615.

135.Lois N, Holder GE, Bunce CV, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 2001;119:359–369.

136.Rabb MF, Tso MO, Fishman GA. Cone-rod dystrophy. A clinical and histopathologic report. Ophthalmology 1986;93:1443–1451.

137.von Ruckmann A, Fitzke FW, Bird AC. Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefe’s Arch Clin Exp Ophthalmol 1999;237:1–9.

138.Fishman GA, Stone EM, Eliason DA, Taylor CM, Liindeman M, Derlacki DJ. ABCA4 gene sequence variationsw in patients with autosomal recessive cone-rod dystrophy. Arch Ophthalmol 2003;121:851–855.

139.Klevering BJ, Maugeri A, Wagner A, et al. Three families displayinng the combination of Stargardt’s disease with cone-rod dystrophy or retinitis pigmentosa. Ophthalmol 2004; 111:546–553.

140.Maugeri A, Klevering BJ, Rohrschneider K, et al. Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. Am J Hum Genet 2000; 67:960–966.

141.Shroyer NF, Lewis RA, Allikmets R, et al. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res 1999;39:2537–2544.

142.Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best’s macular dystrophy. Arch Ophthalmol 1982;100:1108–1114.

143.Frangieh GT, Green WR, Fine SL. A histopathologic study of Best’s macular dystrophy. Arch Ophthalmol 1982;100:1115–1121.

144.Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998;19:241–247.

145.Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA 2002;99: 4008–4013.

146.Marmostein AD, Stanton JB, Yocom J, et al. A model of Best vitelliform macular dystrophy in rats. Invest Ophthalmol Vis Sci 2004;45:3733–3739.

147.Downes SM, Fitzke FW, Holder GD, et al. Clinical features of codon 172 RDS macular dystrophy. Similar phenotype in 12 families. Arch Ophthalmol 1999;117:1373–1383.

148.Hall NA, Lake BD, Dewji NN, Patrick AD. Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten’s disease (ceroid-lipofuscinosis). Biochem J 1991;275:269–272.

149.Haskell RE, Carr CJ, Pearce DA, Bennett MJ, Davidson BL. Batten disease: Evaluation of CLN3 mutations on protein localization and function. Hum Mol Genet 2000; 9:735–744.

150.Katz ML, Gao C, Prabhakaram M, Shibuya H, Liu P, Johnson GS. Immunochemical localization of the Batten disease (CLN3) protein in retina. Invest Ophthalmol Vis Sci 1996;38:2373–2384.

151.Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31:291–306.

152.Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988;32:252–269.

153.Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vision 1999;5:32.

154.Beatty S, Koh H-H, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115–134.

155.Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye 1995;9:763–771.

156.Eldred GE. Lipofuscin fluorophore inhibits lysosomal protein degradation and may cause early stages of macular degeneration. Gerontology 1995;41:15–28.

157.Mainster MA. Light and macular degeneration: A biophysical and clinical perspective. Eye 1987;1:304–310.

158.Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564–572.

159.Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye [see comments]. Arch Ophthalmol 1992;110:99–104.

160.Cruickshanks KJ, Klein R, Klein BEK, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001;119:246–250.

161.Tomany SC, Cruickshanks KJ, Klein R, Klein BEK, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy. The Beaver Dam Eye Study. Arch Ophthalmol 2004;122:750–757.

162.Bernstein PS, Leppert M, Singh N, et al. Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci 2002; 43:466–473.

163.Guymer RH, Heon E, Lotery AJ, et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001;119:745–751.

164.Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmol 1997;104:770–776.

165.Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration. Arch Ophthalmol 2001;119:1463–1468.

166.AREDS Research Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–1708.

167.AREDS Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-related eye disease study report number 3. Ophthalmol 2000;107:2224–2232.

168.Mellerio J. Yellowing of the human lens: nuclear and cortical contributions. Vision Res 1987;27:1581–1587.

169.Mainster MA, Sparrow JR. How much blue light should an IOL transmit? Br J Ophthalmol 2003;87:1523–1529.

170.Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989;79:765–769.

171.Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103:1546–1554.

172.Klein R, Klein BEK, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy. Arch Ophthalmol 2002;120:1551–1558.

173.Wang JJ, Klein R, Smith W, Klein BEK, Tomany SC, Michell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy. Pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 2003;110:1960–1967.